CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 178,087	$ 144,837
Short-term investments	0	3,694
Account receivables, net	154,807	171,233
Inventories	30,731	29,716
Prepaid expenses and other current assets (including restricted cash of $656 and $656 at March 31, 2026, and December 31, 2025)	19,488	17,571
Total current assets	383,113	367,051
Property and equipment, net	6,166	5,959
Other long-term assets (including restricted cash of $332 and $332 at March 31, 2026, and December 31, 2025)	24,272	27,782
Goodwill	30,002	30,002
Intangible asset, net	368,772	379,072
Deferred tax assets	3,312	16,276
TOTAL ASSETS	815,637	826,142
Current liabilities
Accounts payable	12,827	7,884
Accrued expenses and other liabilities	112,773	163,370
Contingent Consideration, short-term	3,176	3,015
Total current liabilities	128,776	174,269
Convertible senior notes, net of deferred financing costs	144,885	144,626
Contingent Consideration, net of current portion	102,397	99,101
Other long-term liabilities	2,530	2,839
TOTAL LIABILITIES	378,588	420,835
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS’ EQUITY
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 91,623 and 91,623 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	0	0
Common stock - $0.001 par value: 160,000,000 shares authorized; 78,395,299 and 79,260,667 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	78	79
Accumulated other comprehensive income	2	3
Additional paid-in capital	574,943	581,800
Accumulated deficit	(137,974)	(176,575)
TOTAL STOCKHOLDERS’ EQUITY	437,049	405,307
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 815,637	$ 826,142